Alivus Life Sciences Gets USFDA Clearance For Dahej Unit

Alivus Life Sciences Ltd. on Friday said the US Food and Drug Administration has completed its inspection of the company’s active pharmaceutical ingredient manufacturing facility in Dahej with no observations.

The inspection was carried out from May 26 to May 30. The company said the successful completion without any Form 483
observations reflects its commitment to quality and compliance.